Bordetella hinzii bacteremia in a patient with SARS-CoV-2 infection

Kamilia Chahia Department of Intensive Care, Cliniques Universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium

Christine Colliennea Department of Intensive Care, Cliniques Universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium

Ahalieyah Anantharajahb Laboratory of Microbiology, Cliniques Universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium

Hector Rodriguez-Villalobosb Laboratory of Microbiology, Cliniques Universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium

Philippe Hantsona Department of Intensive Care, Cliniques Universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium;c Louvain Centre for Toxicology and Applied Pharmacology, Université Catholique de Louvain, Brussels, BelgiumCorrespondence[email protected]

Bordetella hinzii bacteremia in a patient with SARS-CoV-2 infection

Table 1. Antimicrobial susceptibility of Bordetella hinzii isolate using E-test gradient method.

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Bordetella hinzii bacteremia in a patient with SARS-CoV-2 infection

Figures & data

Table 1. Antimicrobial susceptibility of Bordetella hinzii isolate using E-test gradient method.

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date